Literature DB >> 34075521

Elucidating the Possible Role of FoxO in Depression.

Tarapati Rana1,2, Tapan Behl3, Aayush Sehgal1, Vineet Mehta4, Sukhbir Singh1, Neelam Sharma1, Simona Bungau5.   

Abstract

Forkhead box-O (FoxO) transcriptional factors perform essential functions in several physiological and biological processes. Recent studies have shown that FoxO is implicated in the pathophysiology of depression. Changes in the upstream mediators of FoxOs including brain-derived neurotrophic factor (BDNF) and protein kinase B have been associated with depressive disorder and the antidepressant agents are known to alter the phosphorylation of FoxOs. Moreover, FoxOs might be regulated by serotonin or noradrenaline signaling and the hypothalamic-pituitary-adrenal (HPA)-axis,both of them are associated with the development of the depressive disorder. FoxO also regulates neural morphology, synaptogenesis, and neurogenesis in the hippocampus, which accounts for the pathogenesis of the depressive disorder. The current article underlined the potential functions of FoxOs in the etiology of depressive disorder and formulate few essential proposals for further investigation. The review also proposes that FoxO and its signal pathway might establish possible therapeutic mediators for the management of depressive disorder.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antidepressant agents; Depressive disorder; FoxOs; Synaptogenesis; Transcription factors

Mesh:

Substances:

Year:  2021        PMID: 34075521     DOI: 10.1007/s11064-021-03364-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  186 in total

1.  Classical neurotransmitters and neuropeptides involved in major depression in a multi-neurotransmitter system: a focus on antidepressant drugs.

Authors:  Felix-Martin Werner; R Coveñas
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression.

Authors:  P W Gold; G P Chrousos
Journal:  Mol Psychiatry       Date:  2013-06       Impact factor: 15.992

Review 3.  Alliances against depression - A community based approach to target depression and to prevent suicidal behaviour.

Authors:  Ulrich Hegerl; Christine Rummel-Kluge; Airi Värnik; Ella Arensman; Nicole Koburger
Journal:  Neurosci Biobehav Rev       Date:  2013-02-21       Impact factor: 8.989

4.  Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.

Authors:  Steven D Hollon; Robert J DeRubeis; Jan Fawcett; Jay D Amsterdam; Richard C Shelton; John Zajecka; Paula R Young; Robert Gallop
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

5.  White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients.

Authors:  Mardien L Oudega; Eric van Exel; Mike P Wattjes; Hannie C Comijs; Philip Scheltens; Frederik Barkhof; Piet Eikelenboom; Anton J M de Craen; Aartjan T F Beekman; Max L Stek
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

6.  Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.

Authors:  F Pilar-Cuéllar; R Vidal; A Pazos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 7.  Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

Review 8.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

9.  Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.

Authors:  Mi Kyoung Seo; Chan Hong Lee; Hye Yeon Cho; Jung Goo Lee; Bong Ju Lee; Ji Eun Kim; Wongi Seol; Young Hoon Kim; Sung Woo Park
Journal:  Neuropharmacology       Date:  2013-12-01       Impact factor: 5.250

10.  The utility of Mood Disorder Questionnaire for the detection of bipolar diathesis in treatment-resistant depression.

Authors:  Andrzej Kiejna; Tomasz Pawłowski; Dominika Dudek; Dorota Lojko; Marcin Siwek; Robert Roczeń; Janusz K Rybakowski
Journal:  J Affect Disord       Date:  2010-01-13       Impact factor: 4.839

View more
  2 in total

Review 1.  Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2021-09-30

2.  Exploring the mechanisms of action of Cordyceps sinensis for the treatment of depression using network pharmacology and molecular docking.

Authors:  Xingfang Zhang; Mengyuan Wang; Yajun Qiao; Zhongshu Shan; Mengmeng Yang; Guoqiang Li; Yuancan Xiao; Lixin Wei; Hongtao Bi; Tingting Gao
Journal:  Ann Transl Med       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.